Literature DB >> 25750073

[Risk stratification for sudden cardiac death in ischemic heart disease. Programmed ventricular stimulation].

Jürgen Potratz1.   

Abstract

Programmed ventricular stimulation was used extensively in the 1970s and has markedly improved our knowledge about the electrophysiological mechanisms of reentrant ventricular arrhythmias. In numerous observational but also randomized studies, it was shown that the induction of a monomorphic ventricular tachycardia by programmed ventricular stimulation was associated with an increased risk of spontaneous ventricular tachycardia or even sudden cardiac death in the future. Despite these results and the guidelines of ACC and ESC recommending the use of programmed ventricular stimulation in patients with recent and remote myocardial infarction, reduced ejection fraction, and complex ventricular arrhythmias or syncope, programmed ventricular stimulation is only seldom used and does not play a relevant role in clinical practice today. The purpose of this overview is to reevaluate the importance of programmed ventricular stimulation for the risk evaluation of patients with ischemic heart disease in consideration of the current literature.

Entities:  

Mesh:

Year:  2015        PMID: 25750073     DOI: 10.1007/s00399-015-0355-9

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN: 0938-7412


  21 in total

1.  ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death).

Authors:  Douglas P Zipes; A John Camm; Martin Borggrefe; Alfred E Buxton; Bernard Chaitman; Martin Fromer; Gabriel Gregoratos; George Klein; Arthur J Moss; Robert J Myerburg; Silvia G Priori; Miguel A Quinones; Dan M Roden; Michael J Silka; Cynthia Tracy; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Elliott M Antman; Jeffrey L Anderson; Sharon A Hunt; Jonathan L Halperin; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Silvia G Priori; Jean-Jacques Blanc; Andrzej Budaj; A John Camm; Veronica Dean; Jaap W Deckers; Catherine Despres; Kenneth Dickstein; John Lekakis; Keith McGregor; Marco Metra; Joao Morais; Ady Osterspey; Juan Luis Tamargo; José Luis Zamorano
Journal:  J Am Coll Cardiol       Date:  2006-09-05       Impact factor: 24.094

2.  Primary prevention implantable cardioverter defibrillator recipients: the need for defibrillator back-up after an event-free first battery service-life.

Authors:  Guido H Van Welsenes; Johannes B Van Rees; Joep Thijssen; Serge A Trines; Lieselot Van Erven; Martin J Schalij; C J W Borleffs
Journal:  J Cardiovasc Electrophysiol       Date:  2011-07-21

3.  Out-of-hospital cardiac arrest. Use of electrophysiologic testing in the prediction of long-term outcome.

Authors:  D J Wilber; H Garan; D Finkelstein; E Kelly; J Newell; B McGovern; J N Ruskin
Journal:  N Engl J Med       Date:  1988-01-07       Impact factor: 91.245

4.  Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.

Authors:  James P Daubert; Wojciech Zareba; W Jackson Hall; Claudio Schuger; Andrew Corsello; Angel R Leon; Mark L Andrews; Scott McNitt; David T Huang; Arthur J Moss
Journal:  J Am Coll Cardiol       Date:  2005-12-15       Impact factor: 24.094

5.  Long-term prognosis of inducible ventricular flutter: not an innocent finding.

Authors:  Osnat Gurevitz; Sami Viskin; Michael Glikson; Karla V Ballman; A Gabriela Rosales; Win-Kuang Shen; Stephen C Hammill; Paul A Friedman
Journal:  Am Heart J       Date:  2004-04       Impact factor: 4.749

6.  Results and efficiency of programmed ventricular stimulation with four extrastimuli compared with one, two, and three extrastimuli.

Authors:  J D Hummel; S A Strickberger; E Daoud; M Niebauer; O Bakr; K C Man; B D Williamson; F Morady
Journal:  Circulation       Date:  1994-12       Impact factor: 29.690

7.  Long-term outcomes of inducible very fast ventricular tachycardia (cycle length 200-250 ms) in patients with ischemic cardiomyopathy.

Authors:  Saurabh Kumar; Gopal Sivagangabalan; Man-Chun Choi; Vicki Eipper; Aravinda Thiagalingam; Pramesh Kovoor
Journal:  J Cardiovasc Electrophysiol       Date:  2009-10-08

8.  Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial.

Authors:  D S Echt; P R Liebson; L B Mitchell; R W Peters; D Obias-Manno; A H Barker; D Arensberg; A Baker; L Friedman; H L Greene
Journal:  N Engl J Med       Date:  1991-03-21       Impact factor: 91.245

9.  Electrophysiological testing and nonsustained ventricular tachycardia. Use and limitations in patients with coronary artery disease and impaired ventricular function.

Authors:  D J Wilber; B Olshansky; J F Moran; P J Scanlon
Journal:  Circulation       Date:  1990-08       Impact factor: 29.690

10.  Prediction of fatal or near-fatal cardiac arrhythmia events in patients with depressed left ventricular function after an acute myocardial infarction.

Authors:  Heikki V Huikuri; M J Pekka Raatikainen; Rikke Moerch-Joergensen; Juha Hartikainen; Vesa Virtanen; Jean Boland; Olli Anttonen; Nis Hoest; Lucas V A Boersma; Eivind S Platou; Marc D Messier; Poul-Erik Bloch-Thomsen
Journal:  Eur Heart J       Date:  2009-01-20       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.